Aspirin Sensitivity
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)
CES1 Carriers in the PAPI Study
Routine Minimally Invasive Thoracic Surgery Without Aspirin Withdraw
Asprin Dosing Estimator in Healthy Adults
Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand
Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease
Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization